GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Innovation1 Biotech Inc (OTCPK:IVBT) » Definitions » Additional Paid-In Capital

Innovation1 Biotech (Innovation1 Biotech) Additional Paid-In Capital : $55.17 Mil(As of Aug. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Innovation1 Biotech Additional Paid-In Capital?


Innovation1 Biotech's quarterly additional paid-in capital increased from Feb. 2023 ($54.86 Mil) to May. 2023 ($55.17 Mil) but then stayed the same from May. 2023 ($55.17 Mil) to Aug. 2023 ($55.17 Mil).

Innovation1 Biotech's annual additional paid-in capital increased from Aug. 2021 ($2.75 Mil) to Aug. 2022 ($47.38 Mil) and increased from Aug. 2022 ($47.38 Mil) to Aug. 2023 ($55.17 Mil).

Innovation1 Biotech Additional Paid-In Capital Historical Data

The historical data trend for Innovation1 Biotech's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovation1 Biotech Additional Paid-In Capital Chart

Innovation1 Biotech Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only 0.94 1.16 2.75 47.38 55.17

Innovation1 Biotech Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 47.38 47.43 54.86 55.17 55.17

Innovation1 Biotech Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Innovation1 Biotech Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Innovation1 Biotech's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Innovation1 Biotech (Innovation1 Biotech) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Innovation1 Biotech Inc (OTCPK:IVBT) » Definitions » Additional Paid-In Capital
Comparable Companies
NVIV PXMD SCNI PHIO SLRX GBLX SNPX RVLPQ THAR ATXI OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
40 Wall Street, Suite 2701, New York, NY, USA, 10005
Website
https://www.innovation1bio.com
Innovation1 Biotech Inc is a shell company.
Executives
Grays Peak Llc 10 percent owner 8 THE GREEN, STE. A, DOVER DE 19803
Timothy Orr director, 10 percent owner, officer: President 4010 TANAGER LANE, #A, MEAD WA 99021
Darren Long director, 10 percent owner, officer: CEO & Secretary 4010 TANAGER LANE, #A, MEAD WA 99021
Brian Martinho director, 10 percent owner, officer: Treasurer 4010 EAST TANAGER LANE, MEAD WA 99021